Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2005
05/25/2005EP1532097A2 Process for preparing (r)-aryloxypropionic acid ester derivatives
05/25/2005EP1531821A2 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
05/25/2005EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors
05/25/2005EP1531815A1 Glucokinase activators
05/25/2005EP1531673A2 Novel 2-pyridylethylbenzamide derivative
05/25/2005EP1365762A4 Method for increasing leptin levels using nicotinic acid compounds
05/25/2005EP1274684B1 Process for the preparation of aryl-pyridinyl compounds
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides
05/25/2005DE10352067A1 Isopentylcarboxanilide Isopentylcarboxanilide
05/25/2005DE10350722A1 Metallkomplexe Metal complexes
05/25/2005DE10349502A1 1,3-Dimethylbutylcarboxanilide 1,3-Dimethylbutylcarboxanilide
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005DE10341863A1 Verfahren zur Herstellung von 2,3-Pyridindicarbonsäure (Process of Producing 2,3-Pyridinedicarboxylic Acid) A process for the preparation of 2,3-pyridinedicarboxylic acid (Process of Producing 2,3-Pyridinedicarboxylic Acid)
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620421A Substituted alkyl diamine
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203060C Pyridine derivatives, its composition and use
05/25/2005CN1203059C Novel processes for preparing torsemide intermediate
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/24/2005US6897320 With formaldehyde in vapor phase
05/24/2005US6897276 Coordination polymerization catalyst for alpha-olefins
05/24/2005US6897229 Use of PDE4 inhibitor N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide, salts or its N-oxide with PDE3 inhibitor for treatment of obstructions of bronchi
05/24/2005US6897228 Pyridoxine and pyridoxal analogues: new uses
05/24/2005US6897226 NK-1 receptor active amine oxide prodrugs
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents
05/24/2005US6897218 Nitric oxide donors based on metallic centers
05/24/2005US6897198 Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives
05/24/2005US6896891 Non-systemic control of parasites
05/19/2005WO2005044810A1 Glyt2 modulators
05/19/2005WO2005044805A1 A novel process for preparing donepezil and its derivatives
05/19/2005WO2005044801A1 Pyridine carboxylic acid derivatives as glucokinase modulators
05/19/2005WO2005044800A1 Method for producing bactericidal pyridine compound and bactericidal pyridine compound
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/19/2005WO2005044785A1 Aralkyl amines as cannabinoid receptor modulators
05/19/2005WO2005044267A1 Alkynes ii
05/19/2005WO2005044266A1 Alkynes i
05/19/2005WO2005044265A1 Alkynes iii
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005035500A3 Therapeutic agents useful for treating pain
05/19/2005WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors
05/19/2005WO2005016228A3 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005WO2004092100A8 Indene derivatives as pharmaceutical agents
05/19/2005US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors
05/19/2005US20050107469 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/19/2005US20050107468 reacting thioacids with 2-aralkyl acrylic acids in the presence of Lewis acids containing transition metals to from 3-thioacyl-2-aralkylpropionic acids
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107445 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis
05/19/2005US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/19/2005US20050107443 Pyridoxine and pyridoxal analogues: new uses
05/19/2005US20050107437 Novel herbicides
05/19/2005US20050107433 Process for production of optically active compounds
05/19/2005US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
05/19/2005US20050107412 Pharmaceutically active compounds
05/19/2005US20050107397 Sulfonamide derivatives as d3-receptor agonists
05/19/2005US20050107385 Aromatic prodrugs of propofol, compositions and uses thereof
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/19/2005US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
05/19/2005US20050107334 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
05/19/2005US20050107283 Volatile copper (II) complexes and reducing agents for deposition of copper films by atomic layer deposition
05/19/2005US20050106685 Method of synthesizing polynucleotides using ionic liquids
05/19/2005US20050106414 9,9-Dimethylfluorene trimers capped with aromatic amine groups used to produce an organic light-emitting device that exhibits an extremely pure luminescent hue and has a light emission of high efficiency, high brightness, and long lifetime
05/19/2005US20050106109 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
05/19/2005CA2551056A1 Benzo[b][1,4]dioxepine derivatives
05/19/2005CA2549969A1 Alkynes ii
05/19/2005CA2549967A1 Alkynes i
05/19/2005CA2549965A1 Alkynes iii
05/19/2005CA2543882A1 Aralkyl amines as cannabinoid receptor modulators
05/19/2005CA2543643A1 Pyridine carboxylic acid derivatives as glucokinase modulators
05/18/2005EP1531157A1 Cardioprotective phosphonates
05/18/2005EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
05/18/2005EP1259484B1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
05/18/2005EP1250047B9 Herbicidal composition
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005EP0998452B1 Liquid crystal propene or propenyl nitrile derivatives
05/18/2005CN1617948A Volatile copper(II) complexes for deposition of copper films by atomic layer deposition
05/18/2005CN1617865A Phenylalkynes
05/18/2005CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617850A Dibenzylamine compound and medicinal use thereof
05/18/2005CN1617743A New pharmaceutical combinations for nos inhibitors
05/18/2005CN1617723A Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
05/18/2005CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1616471A Organic metal complex compound and organic electroluminescent device said organic complex compound
05/18/2005CN1616453A Antivirally active heterocyclic azahexane derivatives
05/18/2005CN1616452A 维生素d类似物 Vitamin d analogues
05/18/2005CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/18/2005CN1202108C Spiro compounds, preparing method and intermediate
05/18/2005CN1202093C Substituted heterocyclic compound
05/18/2005CN1202083C Method of preparing 4-dimethylamino pyridine
05/18/2005CN1202082C Process for synthesizing 2-Cl-5-trfluoromethyl pyridine
05/17/2005US6894173 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same
05/17/2005US6894169 Zwitterionic chromophores and polymers containing such chromophores
05/17/2005US6894165 Imidazonaphthyridines
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 633